Today, the "2019 Nuclear Medicine and Molecular Imaging New Technology Exchange Conference" was successfully held in Beijing, with over 200 experts, leaders, and manufacturers discussing new technologies and future developments.
The Nuclear Medicine and Molecular Imaging New Technology Exchange Conference serves as a platform to showcase advanced molecular imaging technologies from around the world. This year's conference featured new technologies such as PEC/CT, SPECT, AI and blockchain, and PET/MR, providing attendees with a cutting-edge technology feast.
At the conference, Novel Medical showcased its integrated Micro PET/SPECT/CT product, which features dual-layer crystal DOI detection technology, SiPM-based ASIC digital chip technology, quantitative DOI-PET technology, multi-pinhole confocal SPECT collimator technology, and high-definition CBCT technology. By combining PET, SPECT, and CT modules, it integrates molecular imaging and anatomical imaging for animals, providing reliable quantitative data for the advancement of preclinical medical research. This product offers a crucial technical platform for biomedical and pharmaceutical research in China.
Novel Medical also showcased a variable-angle dual-head SPECT product, which uses fully digital detector technology and has a maximum count rate of 560 kcps. Its dual-head independent control function allows for precise kidney depth measurement, providing a basis for kidney function evaluation. When equipped with an MPH collimator, the SPECT can achieve high-definition, rapid cardiac imaging, improving the accuracy of myocardial ischemia assessment.
The new technologies showcased by Novel Medical attracted significant attention from guests and received praise from experts. The company will continue to innovate independently, deepen its focus on nuclear medicine, and contribute to China's health aspirations!
Finally, congratulations on the successful completion of the 2019 Nuclear Medicine and Molecular Imaging New Technology Exchange Conference!
Language
